During the past decade, a hybrid procedure has emerged and dramatically evolved as an alternative stage I palliation to the conventional Norwood procedure in neonates with hypoplastic left heart syndrome (HLHS). The hybrid approach avoids the need for cardiopulmonary bypass (CPB) utilizing stenting of the arterial duct and bilateral pulmonary artery banding. Cerebral and coronary perfusion pressure is maintained, and the pulmonary vasculature is protected from higher systemic pressure. Elimination of risks associated with CPB gains vital time to stabilize the patient and correct coexisting noncardiac anomalies and allows growth in preparation for the later stages of the Fontan pathway. The association of HLHS with right congenital diaphragm...
Abstract Introduction: Although it only corresponds to 2.5% of congenital heart defects, hypoplasti...
OBJECTIVES To analyse the results of hybrid palliation of hypoplastic left heart syndrome (HLHS) pat...
We report a technique to palliate hypoplastic left heart syndrome, with no PDA stenting, but with do...
During the past decade, a hybrid procedure has emerged and dramatically evolved as an alternative st...
The hybrid approach to management of hypoplastic left heart syndrome (HLHS) was developed as an alte...
In the last decade the hybrid procedure has emerged as an alternative stage I palliation in neonates...
ObjectivesDespite improvements in the surgical management of neonates with the hypoplastic left hear...
The hybrid stage I procedure has emerged as a less-invasive alternative to the standard surgical Nor...
BackgroundThe prognosis of Hypo plastic left heart syndrome is bad and the results remain suboptimal...
BackgroundSurvival after stage I palliation for hypoplastic left heart syndrome or related anomalies...
AbstractNorwood's operation provides satisfactory palliation for neonates with hypoplastic left hear...
The first stage of hypoplastic left heart syndrome (HLHS) palliation typically occurs within the fir...
Norwood's operation provides satisfactory palliation for neonates with hypoplastic left heart syndro...
ObjectiveTwo different strategies have emerged in the initial palliation for hypoplastic left heart ...
ABSTRACT In the current decade, the prognosis of newborns with hypoplastic left heart syndrome, prev...
Abstract Introduction: Although it only corresponds to 2.5% of congenital heart defects, hypoplasti...
OBJECTIVES To analyse the results of hybrid palliation of hypoplastic left heart syndrome (HLHS) pat...
We report a technique to palliate hypoplastic left heart syndrome, with no PDA stenting, but with do...
During the past decade, a hybrid procedure has emerged and dramatically evolved as an alternative st...
The hybrid approach to management of hypoplastic left heart syndrome (HLHS) was developed as an alte...
In the last decade the hybrid procedure has emerged as an alternative stage I palliation in neonates...
ObjectivesDespite improvements in the surgical management of neonates with the hypoplastic left hear...
The hybrid stage I procedure has emerged as a less-invasive alternative to the standard surgical Nor...
BackgroundThe prognosis of Hypo plastic left heart syndrome is bad and the results remain suboptimal...
BackgroundSurvival after stage I palliation for hypoplastic left heart syndrome or related anomalies...
AbstractNorwood's operation provides satisfactory palliation for neonates with hypoplastic left hear...
The first stage of hypoplastic left heart syndrome (HLHS) palliation typically occurs within the fir...
Norwood's operation provides satisfactory palliation for neonates with hypoplastic left heart syndro...
ObjectiveTwo different strategies have emerged in the initial palliation for hypoplastic left heart ...
ABSTRACT In the current decade, the prognosis of newborns with hypoplastic left heart syndrome, prev...
Abstract Introduction: Although it only corresponds to 2.5% of congenital heart defects, hypoplasti...
OBJECTIVES To analyse the results of hybrid palliation of hypoplastic left heart syndrome (HLHS) pat...
We report a technique to palliate hypoplastic left heart syndrome, with no PDA stenting, but with do...